Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Dermatol Surg. 2014 Mar;40(3):305-13. doi: 10.1111/dsu.12415. Epub 2014 Jan 18.
Nonsurgical rhinoplasty involves the use of injectable fillers to improve the contours of the nose. It has become a widely practiced procedure since this author first popularized it in 2003. The use of permanent fillers in nonsurgical rhinoplasty has not been well documented, especially in this country.
To demonstrate the safety and effectiveness of a polymethylmethacrylate (PMMA)-based filler for nonsurgical rhinoplasty.
Eligible subjects underwent up to three injection sessions with a commercially available PMMA product and were followed for 1 year. Efficacy was assessed according to evaluator grading of subjects and digital image analysis of standardized photographs.
Nineteen subjects were enrolled and followed to conclusion. Average improvement in global score was more than one point observed on day 90 and lasting through 1 year. Eight of 10 subjects showed improvement according to digital image analysis at 1 year. Subject satisfaction was high throughout the study. Adverse events were minimal and well tolerated.
Filler rhinoplasty using a PMMA-based injectable filler is safe and effective. This is the first study documenting the use of PMMA for this indication. Longer-term follow-up is needed to demonstrate persistence of improvement.
非手术性隆鼻术涉及使用注射填充剂来改善鼻子的轮廓。自从作者于 2003 年首次推广以来,该手术已得到广泛应用。在非手术性隆鼻术中使用永久性填充物尚未得到充分记录,尤其是在我国。
展示一种基于聚甲基丙烯酸甲酯(PMMA)的填充物在非手术性隆鼻术中的安全性和有效性。
合格的受试者接受了最多三次的商业 PMMA 产品注射,并随访了 1 年。根据评估者对受试者的分级和标准化照片的数字图像分析来评估疗效。
19 名受试者被纳入并随访至结束。在第 90 天观察到整体评分平均提高了超过 1 分,并持续了 1 年。在 1 年时,根据数字图像分析,有 8 名受试者得到了改善。整个研究过程中,受试者满意度很高。不良反应很少,且耐受良好。
使用基于 PMMA 的可注射填充物进行填充物隆鼻术是安全有效的。这是第一项记录 PMMA 在此适应证中应用的研究。需要进行更长时间的随访以证明改善的持久性。